Trial Profile
Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Glucose intolerance
- Focus Therapeutic Use
- 13 May 2010 Results published in Obesity.
- 19 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Jan 2010 Actual patient number (21), lead trial centre added as reported by ClinicalTrials.gov.